tirzepatide discontinuation New research providing further support for obesity drugs When to Stop Tirzepatide: Discontinuation

Researchers examined data from 227,866 people between 2006 and 2023 and found that those taking semaglutide experienced 36 percent fewer alcohol-related hospital visits compared to those not taking the medication

While some medications can be delivered through the skinsuch as estrogen patches used in hormone therapythere are currently no weight loss patches on the market that contain FDA-approved ingredients

On September 29, 2022, the Joint Panel on Multidistrict Litigation (JPML) heard and granted the plaintiffs motion to consolidate all acetaminophen lawsuits that had been filed in Federal Court into a single MDL (multidistrict litigation)

A.EtchesR

Holly Wyatt: If you want to stay connected and continue exploring the Ands of weight loss, be sure to follow our podcast on your favorite platform